相关实验视频

Updated: Jan 10, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

作为多发性骨髓瘤潜在的治疗策略,将过度表达的IDO定位在筋细胞中

Toru Ebina^1,2, Masaki Ri^1,3, Yoshiaki Marumo¹

¹Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

|November 27, 2025

概括

多发性骨髓瘤细胞通过JAK-STAT1-NF-κB-IRF1通路在树皮细胞中升高调节胺二二氧化酶1 (IDO). 简氏激酶 (JAK) 抑制剂可以改善多发性髓瘤的瘤微环境 (TME) 和免疫治疗结果.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

流体细胞在多发性骨髓瘤 (MM) 瘤微环境 (TME) 中至关重要.
印度列胺2,3-二氧化酶1 (IDO) 代谢三烯酸成金氨酸,免疫抑制TME.
较高的金氨酸/氨酸比率与MM患者的预后不佳相关.

研究的目的:

为了阐明MM诱导的IDO上调调节的机制.
在MM TME中识别抑制IDO上调的化合物.

主要方法:

在MM细胞系 (XG-7,IM-9) 与树皮细胞的共同培养中.
用RNA测序来分析信号通路.
西方斑点测试用于评估蛋白质酸化 (STAT1,NF-κB p65).
干扰素调节因子1 (IRF1) 分析和淘汰赛研究.
用氏激酶 (JAK) 抑制剂进行治疗.

主要成果:

在肌肉细胞中,MM细胞对IDO和编程细胞死亡连接物1 (PD-L1) 进行上调.
细胞因子信号通路在共同培养的树皮细胞中被激活.
该JAK-STAT1-NF-κB-IRF1通道与IDO上调有关.
雅克抑制剂和IRF1淘汰显著降低IDO上调.

结论:

在JAK-STAT1-NF-κB-IRF1通路中介的MM诱导的IDO上调在树皮细胞.
用JAK抑制剂向这种途径可以增强MM免疫疗法.
通过IDO抑制调节MM TME提供了一个潜在的治疗策略.

关键词:

在 IDO IDO 里面.在 IRF1 中,IRF1 是 IRF1 的第一个类型.这是一种JAK抑制剂.多发性骨髓瘤是多发性骨髓瘤的一种.这种情况是Stroma Stroma.

更多相关视频

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.